Provider of substance abuse treatment and rehabilitation services. The company operates a 56-bed in-network, inpatient substance abuse treatment facility which includes 20 licensed detoxification beds.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Recovery First‘s full profile, request access.
Request a free trialPitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCompany Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mahajan Therapeutics | Private Equity-Backed | Dayton, OH | 00 | 000000000000 | ||
00000000 000000000 | Private Equity-Backed | Mount Laurel, NJ | 000 | 00000 | 000000000 | 00000 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Debbie Davis | Chief Financial Officer | ||
David Humphries | Clinical Director |